CTS Corporation heads into its October 27 earnings report with short sellers rebuilding positions at an unusual pace, even as the stock holds up near year-to-date highs.
Short interest has climbed 50% over the past month, reaching 4.0% of the free float. The week-on-week jump of nearly 24% is the sharpest single-week move in the 30-day window visible in the data, taking shares short from around 940,000 to just over 1.17 million. That is a meaningful acceleration for a stock that sat below 1% short interest territory as recently as early September. At the same time, the borrow market offers no confirmation of urgency on the short side: availability remains extraordinarily loose at 2,770%, meaning there are roughly 24 million shares available to lend against roughly 1.2 million borrowed. Cost to borrow is a negligible 0.54%, well below the 1.79% that prevailed as recently as August 31. The options market reinforces the relaxed tone. The put/call ratio of 0.019 is actually below its 20-day average, registering about 1.4 standard deviations on the call-heavy side. There is no sign of hedging demand building in the derivatives market ahead of results. The picture that emerges is a short position that is growing fast but remains modest in size and faces no structural squeeze pressure.
Two new analyst initiations in September add a constructive backdrop to an otherwise mixed Street view. Barrington Research started coverage with an Outperform and an $80 target on September 10, while Lake Street's Jaeson Schmidt initiated at Buy with a $67 target on September 2. Both sit above the current price of $59.18, and the mean target across the coverage group is $70.67, implying roughly 19% upside from here. Older ratings from Sidoti and Stephens at Neutral or Equal-Weight provide ballast against outright bullishness, but the direction of new coverage is clearly positive. Valuation multiples are not stretched relative to the initiating targets: the stock trades at 21 times trailing earnings and just under 12 times EV/EBITDA, both of which have drifted slightly lower over the past week. Factor scores show a near-perfect percentile rank of 98 on analyst recommendation divergence, meaning the gap between consensus and the broader analyst universe is unusually wide in CTS's favour. EPS surprise history ranks in the 65th percentile, solid rather than exceptional.
The ownership register adds another layer of interest. GAMCO Asset Management filed a Schedule 13D/A on August 5, an activist-classified filing that carries real weight. GAMCO held 4.1% of the class at that disclosure, just below the 5% threshold, and the 13D designation signals intent beyond a passive stake. Per the ORTEX disclosure note, 13D/G positions are event-driven around the 5% mark, and a holder can fall below 5% without a further filing, so the current exposure is "as last disclosed." Separately, Wasatch Advisors has grown its stake from 10.9% to 12.6%, adding over 1.6 million shares in its most recent reported period to sit as the second-largest holder behind BlackRock's 15.8%. The combination of an active GAMCO filing and a growing Wasatch position suggests institutional conviction in the name is firming, even as short sellers add on the other side.
The insider picture is more nuanced. The 90-day net figure shows roughly 130,000 shares sold worth about $8.5 million, but the bulk of that reflects the former CEO Kieran O'Sullivan's planned exits in June, all executed under a 10b5-1 plan and therefore pre-arranged rather than discretionary. The incoming CEO Pratik Trivedi received a grant of 14,253 shares on July 6, a non-cash award that reads as alignment rather than a conviction buy. On balance, executive-level transaction flow is transitional rather than directional.
The most recent earnings print is worth noting. The Q2 2026 result on July 28 produced a one-day gain of 1.9% and a five-day move of 11.3%, the only comparable data point available. CTS has been a stock that rewards on results rather than into them.
What to watch into October 27 is whether the short interest rebuild continues to accelerate, or whether it plateaus now that it has moved back to a 4% float level, because the answer will determine whether a repeat of the post-Q2 five-day pattern finds any squeeze amplification this time around.
See the live data behind this article on ORTEX.
Open CTS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
